Aurobindo Pharma surges on receiving final approval for drug indicated for HIV treatment

23 May 2012 Evaluate

Aurobindo Pharma is currently trading at Rs. 111.50, up by 1.35 points or 1.23% from its previous closing of Rs. 110.15 on the BSE.

The scrip opened at Rs. 108.35 and has touched a high and low of Rs. 113.40 and Rs. 108.35 respectively. So far 160466 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 188.85 on 27-Jul-2011 and a 52 week low of Rs. 80.35 on 18-Nov-2011.

Last one week high and low of the scrip stood at Rs. 113.14 and Rs. 102.00 respectively. The current market cap of the company is Rs. 3246.00 crore.

The promoters holding in the company stood at 54.76% while Institutions and Non-Institutions held 29.39% and 15.85% respectively. 

Aurobindo Pharma’s tentatively approved ANDA’s for Nevirapine Tablets 200 mg and Nevirapine Oral Suspension 50 mg/5 mL has received the final approval from the US Food & Drug Administration (USFDA). The products have a market size of approximately $125 million for the twelve months ending December 2011 according to the IMS and will be launched soon. Both the products have been approved out of Unit III formulations facility in Hyderabad, India.

Nevirapine Tablets 200 mg and Nevirapine Oral Suspension 50 mg/5 mL are the generic equivalent of Boehringer ingelheim Pharmaceutical Inc’s Viramune Tablets 200 mg and Oral Suspension 50 mg/ 5mL. The products are indicated as part of antiretroviral (ARV) combination therapy for the treatment of Human Immunodeficiency Virus (HIV) infected results.

Aurobindo now has a total of 151 ANDA approvals (125 final approvals including 1 from Aurolife Pharma LLC and 26 tentative approvals) from USFDA.

Aurobindo Pharma has a product presence in key therapeutic segments like SSPs, cephalosporins, antivirals, CNS, cardio-vascular, gastroenterology, etc. The company is the market leader in semi-synthetic penicillin drugs.

Aurobindo Pharma Share Price

1240.70 -14.70 (-1.17%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.